Personalized Risk-based Follow-up of Cervical Cancer Screening in Practice, RCT
This is not medical advice. AI-assisted translation — inaccuracies may occur. Always verify the original and consult your oncologist before taking any steps.
About the trial
The goal of this PREDICT is to assess a personalize approach to screening and management of cervical cancer testing. The investigators will evaluate patients who are due for a follow up cervical cancer screening in the primary care clinics in the Massachusetts General Brigham system. Patients will be randomized by clinic into three different arms (Arm 1: standard care, Arm 2: visit based reminders, Arm 3: visit based reminders and population health outreach)
Original English text from ClinicalTrials.gov
Who can (and can't) join
✓ Qualifies
- •Posiadanie macicy (szyjki macicy) i wiek 21-70 lat
- •Leczenie w klinice podstawowej uczestniczącej w badaniu w ciągu ostatnich 3 lat
- •Wykonanie testu Papanicolaou lub HPV w ciągu ostatnich 3,5 roku
- •Wynik sugerujący podwyższone ryzyko wymagające nadzoru lub dalszych badań
✗ Disqualifies
- •Wcześniejsza diagnoza raka szyjki macicy lub zmian poważnych
- •Usunięta szyjka macicy lub całą macica
- •Brak biegłości w języku angielskim lub hiszpańskim
Simplified criteria — AI translation
Trial details
- Minimum age
- 21 Years
- Maximum age
- 70 Years
- Last updated (source)
- August 7, 2026
- Sex
- Female only
Therapies / drugs in trial
Locations (1)
Massachusetts General Brigham
Boston, United States
Trial contact
Jennifer S Hass, MD
Amy J Wint, MSc
Contact information from ClinicalTrials.gov. Contact in English.
Share this trial
Data from ClinicalTrials.gov. AI-assisted translation, last sync: 8/8/2026.
You can help another person
We fund the Radar, this site, and the development of our Grosz dla Życia fundraising platform from donations and our own resources. Every contribution, even a small one, really helps.